Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow Growth (5y) (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -18.60% |
| Jun 30, 2025 | -41.61% |
| Mar 31, 2025 | -35.18% |
| Dec 31, 2024 | 37.38% |
| Sep 30, 2024 | 25.28% |
| Jun 30, 2024 | 20.79% |
| Mar 31, 2024 | -62.05% |
| Dec 31, 2023 | 16.84% |
| Sep 30, 2023 | 18.35% |
| Jun 30, 2023 | 16.69% |
| Mar 31, 2023 | -25.97% |
| Dec 31, 2022 | -29.35% |
| Sep 30, 2022 | -15.67% |
| Jun 30, 2022 | -39.60% |
| Mar 31, 2022 | -1.16% |
| Dec 31, 2021 | -25.42% |
| Sep 30, 2021 | 18.64% |
| Jun 30, 2021 | -35.12% |
| Mar 31, 2021 | -48.00% |
| Dec 31, 2020 | 44.90% |